146487 To enable the Director to delegate staff, as he deems appropriate, to perform the inspection functions required under this chapter.

DEPARTMENT OF HEALTH

 

NOTICE OF PROPOSED RULEMAKING

 

The Director of the Department of Health, pursuant to the authority set forth in section 19(a)(3) of the District of Columbia Pharmacist and Pharmacy Regulation Act of 1980, effective September 16, 1980 (D.C. Law 3-98; D.C. Official Code § 47-2885.18(a)(3)); section 301 of the District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981, (D. C. Law 4-29; D.C. Official Code § 48-903.01); Mayor’s Order 98-48, dated April 15, 1998 98-48 delegates the Mayor’s authority under Pharmacist Act]; section 4902 of the Fiscal Year 2002 Budget Support Act of 2001, effective October 3, 2001, (D.C. Law 14-28; D.C. Official Code § 7-731); section 15 of the District of Columbia Drug Manufacture and Distribution Licensure Act of 1990, effective June 13 1990, (D.C. Law 8-137; D.C. Official Code § 48-714(a)); and Mayor’s Order 98-88, dated May 29, 1998, hereby gives notice of his intent to take final rulemaking action to adopt the following amendments to Chapter 19 (Pharmacies) of Title 22 (Public Health and Medicine) of the District of Columbia Municipal Regulations (DCMR) in not less than thirty (30) days after the date of publication of this notice in the D.C. Register. 

 

The purpose of these amendments is to enable the Director to delegate staff, as he deems appropriate, to perform the inspection functions required under this chapter. 

 

The following rulemaking action is proposed:

 

CHAPTER 19 (PHARMACIES) is amended as follows:

 

Section 1925.3 is amended to read as follows:

 

1925.3                          The Director may delegate to staff of the Department the authority to conduct inspections of pharmacy operations covered by this chapter.  Inspections shall be conducted upon the issuance of a new license and at least annually thereafter.  Inspections may be conducted more frequently as often as the Director deems necessary or useful.

 

Section 1925.5 is amended to read as follows:

 

1925.5             The Director may delegate to staff of the Department the authority to conduct compliance inspections, audits, and other inspections required under the Act to ensure accountability for all controlled substances and to ensure compliance with laws regulating the practice of pharmacy and the distribution of prescription drugs and devices in the District and all other applicable laws and regulations regarding the practice of pharmacy and the operation of a pharmacy.

 

All persons desiring to comment on the subject matter of this proposed rulemaking action shall submit written comments, not later than thirty (30) days after the date of publication of this notice in the D.C. Register, to Kenneth Campbell, General Counsel, the Department of Health, Office of the General Counsel, 825 North Capitol Street, N.E., 4^th Floor, Washington, D.C. 20002.  Copies of the proposed rules may be obtained between the hours of 9:00 a.m. and 5:00 p.m. at the address listed above.